Clinical Trials Browser

Recruiting × Rituximab × Tumor-Agnostic × Clear all

NCT05615974 2024-12-19

A Phase I/II Study of LM-101 Injection in Patients With Advanced Malignant Tumors

Phase 1/2 Recruiting

Neoplasms